OpenResearchAlpha

Health Security · 17 Nov 2026

Securing Cell-Free Expression: Safeguards for Distributed Biomanufacturing

Liyam Chitayat, Sriharshita Musunuri

0
Citations
no database records one yet
0
Citations in 2026
so far
–
Leading author's h-index
no author has a profile yet
46
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Cell-free expression (CFE) is an acellular biomanufacturing platform capable of producing diverse biomolecules, including proteins, enzymes, and mRNA, outside of living cells. Unlike traditional bioproduction, which requires sterile culture systems and large-scale bioreactors, CFE enables rapid, modular, and decentralized synthesis. CFE extracts can be freeze-dried, stored for extended periods, and reactivated on demand by simply adding a nucleic acid template. This makes it particularly suited for point-of-need applications such as diagnostics, vaccines, and potentially therapeutics in remote, resource-limited, or emergency settings. However, the same features introduce novel biosecurity concerns. Commercially available CFE kits already support the production of bacteriophages and virus-like particles with minimal specialized equipment. As benchtop DNA synthesis and CFE technologies become increasingly accessible, barriers of skill, facilities, and resources are significantly reduced, enabling malicious actors or small autonomous groups to generate harmful biological agents. To address these risks while enabling safe deployment, we recommend: (1) investing in yield optimization and the development of modular, good manufacturing practice-compatible CFE units for distributed manufacturing (performance and scalability); (2) engineering CFE systems with bioorthogonal or otherwise nontransferable components to reduce potential misuse (intrinsic safety feature); and (3) implementing risk-based restrictions for different CFE formulations, balancing innovation with security oversight (tiered access controls). By combining these measures, CFE can be responsibly integrated into global health security infrastructure, delivering its transformative benefits without compromising biosecurity.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (2)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (46)

What it cites, from open citation data, with Crossref's record of each.

Sign in to see 26 more references

A free account opens the rest of the citing papers and references on every paper’s page.

Securing Cell-Free Expression: Safeguards for Distributed Biomanufacturing - QAI OpenResearch